// App-Quantinova.ai

: 986020 in a Phase 2 Clinical Trial in Idiopathic Pulmonary Fibrosis

Researchers

Presenter

  • A. Minnich

Principal Investigators

  • M. Yang

  • S. Du

  • B. Soule

  • Y. Luo

Medical Centers

  • Bristol Myers Squibb, Princeton, New Jersey, United States

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Idiopathic pulmonary fibrosis

Biomarkers

  • Complement Factor B

Drug/Treatment

  • BMS-986020

Outcome

  • N/A

Study Design

  • Placebo Control

  • Cohort

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved